Thomas KLEIN
21Patents
7h-index
30Co-inventors
65Inventor score
Filing activity: Sep 15, 2005 → Apr 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9034883B2 | Vasoprotective and cardioprotective antidiabetic therapy | Chemistry; Metallurgy | 51 | Active |
| US8962636B2 | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions | Chemistry; Metallurgy | 47 | Active |
| US9186392B2 | Combination therapy | Human Necessities | 45 | Active |
| US9149478B2 | Diabetes therapy | Human Necessities | 36 | Active |
| US8883800B2 | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions | Chemistry; Metallurgy | 28 | Active |
| US9199998B2 | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions | Chemistry; Metallurgy | 26 | Active |
| US9192617B2 | Pharmaceutical composition, methods for treating and uses thereof | Emerging Cross-Sectional Technologies | 10 | Active |
| US8697095B1 | Inhibition of replication of oncogenic herpesviruses | Human Necessities | 2 | Active |
| US9526730B2 | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome | Chemistry; Metallurgy | 2 | Active |
| US8735073B2 | Cannabinoid 2 (CB2) receptor gene promoter and unique RNA transcripts in B cells and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10004747B2 | Combination therapy | Human Necessities | 0 | Active |
| US12312352B2 | Use of a DPP-4 inhibitor in SIRS and/or sepsis | Human Necessities | 0 | Active |
| US10195203B2 | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome | Chemistry; Metallurgy | 0 | Active |
| US9289421B2 | Methods and compositions for reducing serum levels of immunoglobulin E (IgE) | Human Necessities | 0 | Active |
| US11911387B2 | Vasoprotective and cardioprotective antidiabetic therapy | Chemistry; Metallurgy | 0 | Active |
| US9713618B2 | Method for modifying food intake and regulating food preference with a DPP-4 inhibitor | Human Necessities | 0 | Active |
| US8242146B2 | Combination of a NSAID and a PDE-4 inhibitor | Human Necessities | 0 | Active |
| US9526728B2 | Medical use of a DPP-4 inhibitor | Human Necessities | 0 | Active |
| US11911388B2 | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | Human Necessities | 0 | Active |
| US8541386B2 | Cannabinoid 2 (CB2) receptor gene promoter and unique RNA transcripts in B cells and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9603851B2 | Combination therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.